Input | HPO ID | HPO term | Distance | Gene | Gene id entrez | HGNC ID | DiseaseId | DiseaseName | Frequency | Onset | HGMD variants | ClinVar variants |
---|
HPO disease - gene - phenotype typical associations: |
HPO disease - gene - phenotype less frequent non-typical associations: |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | AKT1 CL E G H | 207 | 391 | ORPHA:2495 | Meningioma | | | | 54 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | ANOS1 CL E G H | 3730 | 6211 | OMIM:308700 | Hypogonadotropic hypogonadism 1 with or without anosmia | | | | 65 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | AR CL E G H | 367 | 644 | OMIM:300068 | Androgen insensitivity syndrome | | | | 125 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | AR CL E G H | 367 | 644 | ORPHA:99429 | Complete androgen insensitivity syndrome | | | | 125 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | AR CL E G H | 367 | 644 | ORPHA:90797 | Partial androgen insensitivity syndrome | | | | 125 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | BAP1 CL E G H | 8314 | 950 | ORPHA:2495 | Meningioma | | | | 184 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | BMP15 CL E G H | 9210 | 1068 | ORPHA:243 | 46,XX gonadal dysgenesis | | | | 16 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | BMPR1B CL E G H | 658 | 1077 | OMIM:609441 | Acromesomelic dysplasia, Demirhan type | | | | 90 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | BNC1 CL E G H | 646 | 1081 | ORPHA:243 | 46,XX gonadal dysgenesis | | | | | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | BNC1 CL E G H | 646 | 1081 | OMIM:618723 | PREMATURE OVARIAN FAILURE 16; POF16 | | | | | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | C14ORF39 CL E G H | 317761 | 19849 | ORPHA:399805 | Male infertility with azoospermia or oligozoospermia due to single gene mutation | | | | | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | C14ORF39 CL E G H | 317761 | 19849 | OMIM:619203 | PREMATURE OVARIAN FAILURE 18; POF18 | | | | | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | CBX2 CL E G H | 84733 | 1552 | OMIM:613080 | 46XY sex reversal 5 | | | | 3 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | CCDC34 CL E G H | 91057 | 25079 | ORPHA:399805 | Male infertility with azoospermia or oligozoospermia due to single gene mutation | | | | | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | CDH23 CL E G H | 64072 | 13733 | ORPHA:91347 | TSH-secreting pituitary adenoma | | | | 636 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | CFTR CL E G H | 1080 | 1884 | ORPHA:399805 | Male infertility with azoospermia or oligozoospermia due to single gene mutation | | | | 1371 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | CNBP CL E G H | 7555 | 13164 | OMIM:602668 | Dystrophia myotonica 2 | | | | 1 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | CPE CL E G H | 1363 | 2303 | OMIM:619326 | BDV SYNDROME; BDVS | | | | | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | CYB5A CL E G H | 1528 | 2570 | ORPHA:90796 | 46,XY disorder of sex development due to isolated 17,20-lyase deficiency | | | | 2 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | CYP11A1 CL E G H | 1583 | 2590 | ORPHA:168558 | 46,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency | | | | 31 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | CYP11A1 CL E G H | 1583 | 2590 | ORPHA:289548 | Inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency | | | | 31 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | CYP17A1 CL E G H | 1586 | 2593 | ORPHA:90796 | 46,XY disorder of sex development due to isolated 17,20-lyase deficiency | | | | 53 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | CYP17A1 CL E G H | 1586 | 2593 | ORPHA:90793 | Congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency | | | | 53 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | DHH CL E G H | 50846 | 2865 | ORPHA:168563 | 46,XY gonadal dysgenesis-motor and sensory neuropathy syndrome | | | | 21 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | DHX37 CL E G H | 57647 | 17210 | OMIM:273250 | 46, XY sex reversal 11 | | | | 2 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | DHX37 CL E G H | 57647 | 17210 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | | | | 2 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | DIAPH2 CL E G H | 1730 | 2877 | OMIM:300511 | Premature ovarian failure 2A | | | | 6 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | DMRT3 CL E G H | 58524 | 13909 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | | | | 1 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | DMXL2 CL E G H | 23312 | 2938 | ORPHA:453533 | Polyendocrine-polyneuropathy syndrome | | | | 3 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | ERCC6 CL E G H | 2074 | 3438 | OMIM:616946 | PREMATURE OVARIAN FAILURE 11; POF11 | | | | 199 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | ESR1 CL E G H | 2099 | 3467 | ORPHA:785 | Estrogen resistance syndrome | | | | 13 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | ESR2 CL E G H | 2100 | 3468 | OMIM:618187 | Ovarian dysgenesis 8 | | | | | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | FAM111A CL E G H | 63901 | 24725 | ORPHA:93325 | Autosomal dominant Kenny-Caffey syndrome | | | | 8 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | FANCM CL E G H | 57697 | 23168 | ORPHA:399805 | Male infertility with azoospermia or oligozoospermia due to single gene mutation | | | | 107 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | FANCM CL E G H | 57697 | 23168 | OMIM:618086 | Spermatogenic failure 28 | | | | 107 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | FGD1 CL E G H | 2245 | 3663 | OMIM:305400 | Aarskog-Scott syndrome | | | | 62 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | FIGLA CL E G H | 344018 | 24669 | OMIM:612310 | PREMATURE OVARIAN FAILURE 6; POF6 | | | | 17 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | FKBP6 CL E G H | 8468 | 3722 | OMIM:620103 | | | | | | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | FMR1 CL E G H | 2332 | 3775 | OMIM:311360 | Premature ovarian failure 1 | | | | 30 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | FOXL2 CL E G H | 668 | 1092 | OMIM:110100 | Blepharophimosis, epicanthus inversus, and ptosis | | | | 92 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | FOXL2 CL E G H | 668 | 1092 | ORPHA:572333 | Blepharophimosis-ptosis-epicanthus inversus syndrome plus | | | | 92 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | FSHB CL E G H | 2488 | 3964 | OMIM:229070 | Hypogonadotropic hypogonadism 24 without anosmia | | | | 23 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | FSHR CL E G H | 2492 | 3969 | ORPHA:243 | 46,XX gonadal dysgenesis | | | | 50 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | FSHR CL E G H | 2492 | 3969 | OMIM:233300 | Ovarian dysgenesis 1 | | | | 50 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | FSHR CL E G H | 2492 | 3969 | ORPHA:64739 | Ovarian hyperstimulation syndrome | | | | 50 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | GATA4 CL E G H | 2626 | 4173 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | | | | 87 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | GCNA CL E G H | 93953 | 15805 | OMIM:301077 | SPERMATOGENIC FAILURE, X-LINKED, 4; SPGFX4 | | | | | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | GDF9 CL E G H | 2661 | 4224 | OMIM:618014 | Premature ovarian failure 14 | | | | 2 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | GNRH1 CL E G H | 2796 | 4419 | OMIM:614841 | Hypogonadotropic hypogonadism 12 with or without anosmia | | | | 15 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | HESX1 CL E G H | 8820 | 4877 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | | | | 21 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | HFM1 CL E G H | 164045 | 20193 | OMIM:615724 | Premature ovarian failure 9 | | | | 6 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | HSD17B4 CL E G H | 3295 | 5213 | OMIM:233400 | Perrault syndrome 1 | | | | 98 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | KISS1 CL E G H | 3814 | 6341 | OMIM:614842 | Hypogonadotropic hypogonadism 13 with or without anosmia | | | | 3 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | KISS1R CL E G H | 84634 | 4510 | OMIM:176400 | Precocious puberty, central | | | | 14 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | KLHL10 CL E G H | 317719 | 18829 | ORPHA:399805 | Male infertility with azoospermia or oligozoospermia due to single gene mutation | | | | 3 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | LARS2 CL E G H | 23395 | 17095 | OMIM:615300 | Perrault syndrome 4 | | | | 54 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | LGR4 CL E G H | 55366 | 13299 | OMIM:619613 | DELAYED PUBERTY, SELF-LIMITED; DPSL | | | | 1 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | LHB CL E G H | 3972 | 6584 | OMIM:228300 | Hypogonadotropic hypogonadism 23 without anosmia | | | | 9 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | LHCGR CL E G H | 3973 | 6585 | OMIM:238320 | Hypergonadotropic hypogonadism | | | | 67 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | LHX3 CL E G H | 8022 | 6595 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | | | | 51 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | LHX4 CL E G H | 89884 | 21734 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | | | | 43 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | MAGEL2 CL E G H | 54551 | 6814 | ORPHA:98754 | Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15 | | | | 63 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | MAGEL2 CL E G H | 54551 | 6814 | ORPHA:177901 | Prader-Willi syndrome due to paternal deletion of 15q11q13 type 1 | | | | 63 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | MAGEL2 CL E G H | 54551 | 6814 | ORPHA:177904 | Prader-Willi syndrome due to paternal deletion of 15q11q13 type 2 | | | | 63 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | MAP3K1 CL E G H | 4214 | 6848 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | | | | 13 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | MCM8 CL E G H | 84515 | 16147 | OMIM:612885 | Premature ovarian failure 10 | | | | 4 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | MCM9 CL E G H | 254394 | 21484 | OMIM:616185 | Ovarian dysgenesis 4 | | | | 4 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | MEIOB CL E G H | 254528 | 28569 | ORPHA:399805 | Male infertility with azoospermia or oligozoospermia due to single gene mutation | | | | | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | MRPS22 CL E G H | 56945 | 14508 | ORPHA:243 | 46,XX gonadal dysgenesis | | | | 25 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | MSH4 CL E G H | 4438 | 7327 | OMIM:619938 | | | | | | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | MSH5 CL E G H | 4439 | 7328 | OMIM:617442 | Premature ovarian failure 13 | | | | 5 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | NANOS1 CL E G H | 340719 | 23044 | ORPHA:399805 | Male infertility with azoospermia or oligozoospermia due to single gene mutation | | | | 4 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | NANOS1 CL E G H | 340719 | 23044 | ORPHA:399808 | Male infertility with teratozoospermia due to single gene mutation | | | | 4 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | NDN CL E G H | 4692 | 7675 | ORPHA:98754 | Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15 | | | | | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | NDN CL E G H | 4692 | 7675 | ORPHA:177901 | Prader-Willi syndrome due to paternal deletion of 15q11q13 type 1 | | | | | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | NDN CL E G H | 4692 | 7675 | ORPHA:177904 | Prader-Willi syndrome due to paternal deletion of 15q11q13 type 2 | | | | | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | NF2 CL E G H | 4771 | 7773 | ORPHA:2495 | Meningioma | | | | 220 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | NHLH2 CL E G H | 4808 | 7818 | OMIM:619755 | HYPOGONADOTROPIC HYPOGONADISM 27 WITHOUT ANOSMIA; HH27 | | | | | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | NR0B1 CL E G H | 190 | 7960 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | | | | 48 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | NR5A1 CL E G H | 2516 | 7983 | ORPHA:243 | 46,XX gonadal dysgenesis | | | | 38 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | NR5A1 CL E G H | 2516 | 7983 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | | | | 38 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | NR5A1 CL E G H | 2516 | 7983 | OMIM:612965 | 46XY sex reversal 3 | | | | 38 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | NR5A1 CL E G H | 2516 | 7983 | ORPHA:399805 | Male infertility with azoospermia or oligozoospermia due to single gene mutation | | | | 38 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | NR5A1 CL E G H | 2516 | 7983 | OMIM:612964 | PREMATURE OVARIAN FAILURE 7; POF7 | | | | 38 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | NSMCE2 CL E G H | 286053 | 26513 | OMIM:617253 | Seckel syndrome 10 | | | | 2 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | NUP107 CL E G H | 57122 | 29914 | ORPHA:243 | 46,XX gonadal dysgenesis | | | | 5 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | OCA2 CL E G H | 4948 | 8101 | ORPHA:98754 | Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15 | | | | 121 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | OCA2 CL E G H | 4948 | 8101 | ORPHA:177901 | Prader-Willi syndrome due to paternal deletion of 15q11q13 type 1 | | | | 121 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | OCA2 CL E G H | 4948 | 8101 | ORPHA:177904 | Prader-Willi syndrome due to paternal deletion of 15q11q13 type 2 | | | | 121 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | OTX2 CL E G H | 5015 | 8522 | OMIM:613986 | Pituitary hormone deficiency, combined, 6 | | | | 41 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | PDGFB CL E G H | 5155 | 8800 | ORPHA:2495 | Meningioma | | | | 9 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | PIK3CA CL E G H | 5290 | 8975 | ORPHA:2495 | Meningioma | | | | 162 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | PNLDC1 CL E G H | 154197 | 21185 | ORPHA:399805 | Male infertility with azoospermia or oligozoospermia due to single gene mutation | | | | | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | PNPLA6 CL E G H | 10908 | 16268 | OMIM:215470 | Boucher-Neuhauser syndrome | | | | 103 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | POLA1 CL E G H | 5422 | 9173 | ORPHA:163976 | X-linked intellectual disability, Van Esch type | | | | 2 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | POLR3H CL E G H | 171568 | 30349 | ORPHA:243 | 46,XX gonadal dysgenesis | | | | | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | POR CL E G H | 5447 | 9208 | ORPHA:95699 | Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency | | | | 76 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | POU1F1 CL E G H | 5449 | 9210 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | | | | 36 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | PPP2R3C CL E G H | 55012 | 17485 | OMIM:618419 | Gonadal dysgenesis, dysmorphic facies, retinal dystrophy, and myopathy | | | | | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | PRDM13 CL E G H | 59336 | 13998 | OMIM:619761 | CEREBELLAR DYSFUNCTION, IMPAIRED INTELLECTUAL DEVELOPMENT, AND HYPOGONADOTROPIC HYPOGONADISM; CDIDHH | | | | 2 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | PROP1 CL E G H | 5626 | 9455 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | | | | 54 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | PSMC3IP CL E G H | 29893 | 17928 | ORPHA:243 | 46,XX gonadal dysgenesis | | | | 2 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | PSMC3IP CL E G H | 29893 | 17928 | OMIM:614324 | Ovarian dysgenesis 3 | | | | 2 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | SEMA3A CL E G H | 10371 | 10723 | OMIM:614897 | Hypogonadotropic hypogonadism 16 with or without anosmia | | | | 14 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | SHOC1 CL E G H | 158401 | 26535 | OMIM:619949 | | | | | | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | SMARCB1 CL E G H | 6598 | 11103 | ORPHA:2495 | Meningioma | | | | 87 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | SMARCE1 CL E G H | 6605 | 11109 | ORPHA:2495 | Meningioma | | | | 47 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | SMO CL E G H | 6608 | 11119 | ORPHA:2495 | Meningioma | | | | 22 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | SNRPN CL E G H | 6638 | 11164 | ORPHA:98754 | Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15 | | | | 37 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | SNRPN CL E G H | 6638 | 11164 | ORPHA:177901 | Prader-Willi syndrome due to paternal deletion of 15q11q13 type 1 | | | | 37 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | SNRPN CL E G H | 6638 | 11164 | ORPHA:177904 | Prader-Willi syndrome due to paternal deletion of 15q11q13 type 2 | | | | 37 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | SOHLH1 CL E G H | 402381 | 27845 | ORPHA:399805 | Male infertility with azoospermia or oligozoospermia due to single gene mutation | | | | 3 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | SOX9 CL E G H | 6662 | 11204 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | | | | 109 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | SPIDR CL E G H | 23514 | 28971 | ORPHA:243 | 46,XX gonadal dysgenesis | | | | 2 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | SPIDR CL E G H | 23514 | 28971 | OMIM:619665 | OVARIAN DYSGENESIS 9; ODG9 | | | | 2 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | SRY CL E G H | 6736 | 11311 | ORPHA:1772 | 45,X/46,XY mixed gonadal dysgenesis | | | | 23 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | SRY CL E G H | 6736 | 11311 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | | | | 23 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | SRY CL E G H | 6736 | 11311 | OMIM:400045 | 46XX sex reversal 1 | | | | 23 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | SRY CL E G H | 6736 | 11311 | OMIM:400044 | 46XY sex reversal 1 | | | | 23 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | STAG3 CL E G H | 10734 | 11356 | OMIM:615723 | Premature ovarian failure 8 | | | | 4 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | SUFU CL E G H | 51684 | 16466 | ORPHA:2495 | Meningioma | | | | 124 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | SYCE1 CL E G H | 93426 | 28852 | ORPHA:399805 | Male infertility with azoospermia or oligozoospermia due to single gene mutation | | | | 4 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | SYCP3 CL E G H | 50511 | 18130 | ORPHA:399805 | Male infertility with azoospermia or oligozoospermia due to single gene mutation | | | | 12 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | TAF4B CL E G H | 6875 | 11538 | ORPHA:399805 | Male infertility with azoospermia or oligozoospermia due to single gene mutation | | | | 1 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | TDRD9 CL E G H | 122402 | 20122 | ORPHA:399805 | Male infertility with azoospermia or oligozoospermia due to single gene mutation | | | | | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | TERT CL E G H | 7015 | 11730 | ORPHA:2495 | Meningioma | | | | 238 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | TEX11 CL E G H | 56159 | 11733 | ORPHA:399805 | Male infertility with azoospermia or oligozoospermia due to single gene mutation | | | | 5 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | TEX14 CL E G H | 56155 | 11737 | ORPHA:399805 | Male infertility with azoospermia or oligozoospermia due to single gene mutation | | | | 1 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | TEX15 CL E G H | 56154 | 11738 | ORPHA:399805 | Male infertility with azoospermia or oligozoospermia due to single gene mutation | | | | 1 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | TRAF7 CL E G H | 84231 | 20456 | ORPHA:2495 | Meningioma | | | | | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | VAMP7 CL E G H | 6845 | 11486 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | | | | 2 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | WT1 CL E G H | 7490 | 12796 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | | | | 177 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | WT1 CL E G H | 7490 | 12796 | ORPHA:347 | Frasier syndrome | | | | 177 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | WWOX CL E G H | 51741 | 12799 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | | | | 149 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | XRCC2 CL E G H | 7516 | 12829 | ORPHA:399805 | Male infertility with azoospermia or oligozoospermia due to single gene mutation | | | | 125 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | XRCC2 CL E G H | 7516 | 12829 | OMIM:619146 | PREMATURE OVARIAN FAILURE 17; POF17 | | | | 125 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | ZFPM2 CL E G H | 23414 | 16700 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | | | | 31 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | ZMYND15 CL E G H | 84225 | 20997 | ORPHA:399805 | Male infertility with azoospermia or oligozoospermia due to single gene mutation | | | | 1 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | ZMYND15 CL E G H | 84225 | 20997 | OMIM:615842 | Spermatogenic failure 14 | | | | 1 | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | ZSWIM7 CL E G H | 125150 | 26993 | ORPHA:243 | 46,XX gonadal dysgenesis | | | | | | |
HP:0030338 | HP:0030338 | Abnormal circulating gonadotropin concentration | 0 | ZSWIM7 CL E G H | 125150 | 26993 | OMIM:619834 | OVARIAN DYSGENESIS 10; ODG10 | | | | | | |
HP:0030338 | HP:0030339 | Decreased circulating gonadotropin concentration | 1 | AKT1 CL E G H | 207 | 391 | ORPHA:2495 | Meningioma | | | | 54 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | AKT1 CL E G H | 207 | 391 | ORPHA:2495 | Meningioma | | | | 54 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | AKT1 CL E G H | 207 | 391 | ORPHA:2495 | Meningioma | | | | 54 | | |
HP:0030338 | HP:0030339 | Decreased circulating gonadotropin concentration | 1 | ANOS1 CL E G H | 3730 | 6211 | OMIM:308700 | Hypogonadotropic hypogonadism 1 with or without anosmia | | | | 65 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | ANOS1 CL E G H | 3730 | 6211 | OMIM:308700 | Hypogonadotropic hypogonadism 1 with or without anosmia | | | | 65 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | ANOS1 CL E G H | 3730 | 6211 | OMIM:308700 | Hypogonadotropic hypogonadism 1 with or without anosmia | | | | 65 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | AR CL E G H | 367 | 644 | OMIM:300068 | Androgen insensitivity syndrome | | | | 125 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | AR CL E G H | 367 | 644 | OMIM:300068 | Androgen insensitivity syndrome | | | | 125 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | AR CL E G H | 367 | 644 | OMIM:300068 | Androgen insensitivity syndrome | | | | 125 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | AR CL E G H | 367 | 644 | ORPHA:99429 | Complete androgen insensitivity syndrome | | | | 125 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | AR CL E G H | 367 | 644 | ORPHA:99429 | Complete androgen insensitivity syndrome | HP:0040284 - Very rare | | | 125 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | AR CL E G H | 367 | 644 | ORPHA:99429 | Complete androgen insensitivity syndrome | | | | 125 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | AR CL E G H | 367 | 644 | ORPHA:90797 | Partial androgen insensitivity syndrome | | | | 125 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | AR CL E G H | 367 | 644 | ORPHA:90797 | Partial androgen insensitivity syndrome | | | | 125 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | BAP1 CL E G H | 8314 | 950 | ORPHA:2495 | Meningioma | | | | 184 | | |
HP:0030338 | HP:0030339 | Decreased circulating gonadotropin concentration | 1 | BAP1 CL E G H | 8314 | 950 | ORPHA:2495 | Meningioma | | | | 184 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | BAP1 CL E G H | 8314 | 950 | ORPHA:2495 | Meningioma | | | | 184 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | BMP15 CL E G H | 9210 | 1068 | ORPHA:243 | 46,XX gonadal dysgenesis | HP:0040281 - Very frequent | | | 16 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | BMPR1B CL E G H | 658 | 1077 | OMIM:609441 | Acromesomelic dysplasia, Demirhan type | | | | 90 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | BMPR1B CL E G H | 658 | 1077 | OMIM:609441 | Acromesomelic dysplasia, Demirhan type | | | | 90 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | BMPR1B CL E G H | 658 | 1077 | OMIM:609441 | Acromesomelic dysplasia, Demirhan type | | | | 90 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | BNC1 CL E G H | 646 | 1081 | ORPHA:243 | 46,XX gonadal dysgenesis | HP:0040281 - Very frequent | | | | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | BNC1 CL E G H | 646 | 1081 | OMIM:618723 | PREMATURE OVARIAN FAILURE 16; POF16 | | | | | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | BNC1 CL E G H | 646 | 1081 | OMIM:618723 | PREMATURE OVARIAN FAILURE 16; POF16 | | | | | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | C14ORF39 CL E G H | 317761 | 19849 | ORPHA:399805 | Male infertility with azoospermia or oligozoospermia due to single gene mutation | HP:0040281 - Very frequent | | | | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | C14ORF39 CL E G H | 317761 | 19849 | OMIM:619203 | PREMATURE OVARIAN FAILURE 18; POF18 | | | | | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | C14ORF39 CL E G H | 317761 | 19849 | OMIM:619203 | PREMATURE OVARIAN FAILURE 18; POF18 | | | | | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | C14ORF39 CL E G H | 317761 | 19849 | OMIM:619203 | PREMATURE OVARIAN FAILURE 18; POF18 | | | | | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | CBX2 CL E G H | 84733 | 1552 | OMIM:613080 | 46XY sex reversal 5 | | | | 3 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | CBX2 CL E G H | 84733 | 1552 | OMIM:613080 | 46XY sex reversal 5 | | | | 3 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | CCDC34 CL E G H | 91057 | 25079 | ORPHA:399805 | Male infertility with azoospermia or oligozoospermia due to single gene mutation | HP:0040281 - Very frequent | | | | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | CDH23 CL E G H | 64072 | 13733 | ORPHA:91347 | TSH-secreting pituitary adenoma | HP:0040283 - Occasional | | | 636 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | CFTR CL E G H | 1080 | 1884 | ORPHA:399805 | Male infertility with azoospermia or oligozoospermia due to single gene mutation | HP:0040281 - Very frequent | | | 1371 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | CNBP CL E G H | 7555 | 13164 | OMIM:602668 | Dystrophia myotonica 2 | | | | 1 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | CNBP CL E G H | 7555 | 13164 | OMIM:602668 | Dystrophia myotonica 2 | | | | 1 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | CPE CL E G H | 1363 | 2303 | OMIM:619326 | BDV SYNDROME; BDVS | | | | | | |
HP:0030338 | HP:0030339 | Decreased circulating gonadotropin concentration | 1 | CPE CL E G H | 1363 | 2303 | OMIM:619326 | BDV SYNDROME; BDVS | | | | | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | CYB5A CL E G H | 1528 | 2570 | ORPHA:90796 | 46,XY disorder of sex development due to isolated 17,20-lyase deficiency | | | | 2 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | CYB5A CL E G H | 1528 | 2570 | ORPHA:90796 | 46,XY disorder of sex development due to isolated 17,20-lyase deficiency | | | | 2 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | CYB5A CL E G H | 1528 | 2570 | ORPHA:90796 | 46,XY disorder of sex development due to isolated 17,20-lyase deficiency | | | | 2 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | CYP11A1 CL E G H | 1583 | 2590 | ORPHA:168558 | 46,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency | | | | 31 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | CYP11A1 CL E G H | 1583 | 2590 | ORPHA:168558 | 46,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency | | | | 31 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | CYP11A1 CL E G H | 1583 | 2590 | ORPHA:168558 | 46,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency | | | | 31 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | CYP11A1 CL E G H | 1583 | 2590 | ORPHA:289548 | Inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency | | | | 31 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | CYP11A1 CL E G H | 1583 | 2590 | ORPHA:289548 | Inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency | | | | 31 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | CYP11A1 CL E G H | 1583 | 2590 | ORPHA:289548 | Inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency | | | | 31 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | CYP17A1 CL E G H | 1586 | 2593 | ORPHA:90796 | 46,XY disorder of sex development due to isolated 17,20-lyase deficiency | | | | 53 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | CYP17A1 CL E G H | 1586 | 2593 | ORPHA:90796 | 46,XY disorder of sex development due to isolated 17,20-lyase deficiency | | | | 53 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | CYP17A1 CL E G H | 1586 | 2593 | ORPHA:90796 | 46,XY disorder of sex development due to isolated 17,20-lyase deficiency | | | | 53 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | CYP17A1 CL E G H | 1586 | 2593 | ORPHA:90793 | Congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency | | | | 53 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | CYP17A1 CL E G H | 1586 | 2593 | ORPHA:90793 | Congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency | HP:0040281 - Very frequent | | | 53 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | CYP17A1 CL E G H | 1586 | 2593 | ORPHA:90793 | Congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency | | | | 53 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | DHH CL E G H | 50846 | 2865 | ORPHA:168563 | 46,XY gonadal dysgenesis-motor and sensory neuropathy syndrome | HP:0040281 - Very frequent | | | 21 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | DHX37 CL E G H | 57647 | 17210 | OMIM:273250 | 46, XY sex reversal 11 | | | | 2 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | DHX37 CL E G H | 57647 | 17210 | OMIM:273250 | 46, XY sex reversal 11 | | | | 2 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | DHX37 CL E G H | 57647 | 17210 | OMIM:273250 | 46, XY sex reversal 11 | | | | 2 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | DHX37 CL E G H | 57647 | 17210 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | | | | 2 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | DHX37 CL E G H | 57647 | 17210 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | | | | 2 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | DHX37 CL E G H | 57647 | 17210 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | HP:0040281 - Very frequent | | | 2 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | DIAPH2 CL E G H | 1730 | 2877 | OMIM:300511 | Premature ovarian failure 2A | | | | 6 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | DIAPH2 CL E G H | 1730 | 2877 | OMIM:300511 | Premature ovarian failure 2A | | | | 6 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | DIAPH2 CL E G H | 1730 | 2877 | OMIM:300511 | Premature ovarian failure 2A | | | | 6 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | DMRT3 CL E G H | 58524 | 13909 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | | | | 1 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | DMRT3 CL E G H | 58524 | 13909 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | | | | 1 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | DMRT3 CL E G H | 58524 | 13909 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | HP:0040281 - Very frequent | | | 1 | | |
HP:0030338 | HP:0030339 | Decreased circulating gonadotropin concentration | 1 | DMXL2 CL E G H | 23312 | 2938 | ORPHA:453533 | Polyendocrine-polyneuropathy syndrome | | | | 3 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | DMXL2 CL E G H | 23312 | 2938 | ORPHA:453533 | Polyendocrine-polyneuropathy syndrome | | | | 3 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | DMXL2 CL E G H | 23312 | 2938 | ORPHA:453533 | Polyendocrine-polyneuropathy syndrome | | | | 3 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | ERCC6 CL E G H | 2074 | 3438 | OMIM:616946 | PREMATURE OVARIAN FAILURE 11; POF11 | | | | 199 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | ERCC6 CL E G H | 2074 | 3438 | OMIM:616946 | PREMATURE OVARIAN FAILURE 11; POF11 | | | | 199 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | ESR1 CL E G H | 2099 | 3467 | ORPHA:785 | Estrogen resistance syndrome | HP:0040281 - Very frequent | | | 13 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | ESR2 CL E G H | 2100 | 3468 | OMIM:618187 | Ovarian dysgenesis 8 | | | | | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | ESR2 CL E G H | 2100 | 3468 | OMIM:618187 | Ovarian dysgenesis 8 | | | | | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | ESR2 CL E G H | 2100 | 3468 | OMIM:618187 | Ovarian dysgenesis 8 | | | | | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | FAM111A CL E G H | 63901 | 24725 | ORPHA:93325 | Autosomal dominant Kenny-Caffey syndrome | HP:0040282 - Frequent | | | 8 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | FANCM CL E G H | 57697 | 23168 | ORPHA:399805 | Male infertility with azoospermia or oligozoospermia due to single gene mutation | HP:0040281 - Very frequent | | | 107 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | FANCM CL E G H | 57697 | 23168 | OMIM:618086 | Spermatogenic failure 28 | | | | 107 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | FANCM CL E G H | 57697 | 23168 | OMIM:618086 | Spermatogenic failure 28 | | | | 107 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | FANCM CL E G H | 57697 | 23168 | OMIM:618086 | Spermatogenic failure 28 | | | | 107 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | FGD1 CL E G H | 2245 | 3663 | OMIM:305400 | Aarskog-Scott syndrome | | | | 62 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | FGD1 CL E G H | 2245 | 3663 | OMIM:305400 | Aarskog-Scott syndrome | | | | 62 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | FGD1 CL E G H | 2245 | 3663 | OMIM:305400 | Aarskog-Scott syndrome | | | | 62 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | FIGLA CL E G H | 344018 | 24669 | OMIM:612310 | PREMATURE OVARIAN FAILURE 6; POF6 | | | | 17 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | FIGLA CL E G H | 344018 | 24669 | OMIM:612310 | PREMATURE OVARIAN FAILURE 6; POF6 | | | | 17 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | FIGLA CL E G H | 344018 | 24669 | OMIM:612310 | PREMATURE OVARIAN FAILURE 6; POF6 | | | | 17 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | FKBP6 CL E G H | 8468 | 3722 | OMIM:620103 | | | | | | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | FKBP6 CL E G H | 8468 | 3722 | OMIM:620103 | | | | | | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | FMR1 CL E G H | 2332 | 3775 | OMIM:311360 | Premature ovarian failure 1 | . | | | 30 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | FOXL2 CL E G H | 668 | 1092 | OMIM:110100 | Blepharophimosis, epicanthus inversus, and ptosis | . | | | 92 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | FOXL2 CL E G H | 668 | 1092 | ORPHA:572333 | Blepharophimosis-ptosis-epicanthus inversus syndrome plus | | | | 92 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | FOXL2 CL E G H | 668 | 1092 | ORPHA:572333 | Blepharophimosis-ptosis-epicanthus inversus syndrome plus | | | | 92 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | FOXL2 CL E G H | 668 | 1092 | ORPHA:572333 | Blepharophimosis-ptosis-epicanthus inversus syndrome plus | | | | 92 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | FSHB CL E G H | 2488 | 3964 | OMIM:229070 | Hypogonadotropic hypogonadism 24 without anosmia | | | | 23 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | FSHB CL E G H | 2488 | 3964 | OMIM:229070 | Hypogonadotropic hypogonadism 24 without anosmia | | | | 23 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | FSHB CL E G H | 2488 | 3964 | OMIM:229070 | Hypogonadotropic hypogonadism 24 without anosmia | | | | 23 | | |
HP:0030338 | HP:0030339 | Decreased circulating gonadotropin concentration | 1 | FSHB CL E G H | 2488 | 3964 | OMIM:229070 | Hypogonadotropic hypogonadism 24 without anosmia | | | | 23 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | FSHR CL E G H | 2492 | 3969 | ORPHA:243 | 46,XX gonadal dysgenesis | HP:0040281 - Very frequent | | | 50 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | FSHR CL E G H | 2492 | 3969 | OMIM:233300 | Ovarian dysgenesis 1 | . | | | 50 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | FSHR CL E G H | 2492 | 3969 | ORPHA:64739 | Ovarian hyperstimulation syndrome | HP:0040281 - Very frequent | | | 50 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | GATA4 CL E G H | 2626 | 4173 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | HP:0040281 - Very frequent | | | 87 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | GATA4 CL E G H | 2626 | 4173 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | | | | 87 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | GATA4 CL E G H | 2626 | 4173 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | | | | 87 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | GCNA CL E G H | 93953 | 15805 | OMIM:301077 | SPERMATOGENIC FAILURE, X-LINKED, 4; SPGFX4 | | | | | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | GCNA CL E G H | 93953 | 15805 | OMIM:301077 | SPERMATOGENIC FAILURE, X-LINKED, 4; SPGFX4 | | | | | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | GCNA CL E G H | 93953 | 15805 | OMIM:301077 | SPERMATOGENIC FAILURE, X-LINKED, 4; SPGFX4 | | | | | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | GDF9 CL E G H | 2661 | 4224 | OMIM:618014 | Premature ovarian failure 14 | | | | 2 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | GDF9 CL E G H | 2661 | 4224 | OMIM:618014 | Premature ovarian failure 14 | | | | 2 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | GDF9 CL E G H | 2661 | 4224 | OMIM:618014 | Premature ovarian failure 14 | | | | 2 | | |
HP:0030338 | HP:0030339 | Decreased circulating gonadotropin concentration | 1 | GNRH1 CL E G H | 2796 | 4419 | OMIM:614841 | Hypogonadotropic hypogonadism 12 with or without anosmia | . | | | 15 | | |
HP:0030338 | HP:0030339 | Decreased circulating gonadotropin concentration | 1 | HESX1 CL E G H | 8820 | 4877 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | | | | 21 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | HESX1 CL E G H | 8820 | 4877 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | | | | 21 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | HESX1 CL E G H | 8820 | 4877 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | | | | 21 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | HFM1 CL E G H | 164045 | 20193 | OMIM:615724 | Premature ovarian failure 9 | . | | | 6 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | HSD17B4 CL E G H | 3295 | 5213 | OMIM:233400 | Perrault syndrome 1 | . | | | 98 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | KISS1 CL E G H | 3814 | 6341 | OMIM:614842 | Hypogonadotropic hypogonadism 13 with or without anosmia | | | | 3 | | |
HP:0030338 | HP:0030339 | Decreased circulating gonadotropin concentration | 1 | KISS1 CL E G H | 3814 | 6341 | OMIM:614842 | Hypogonadotropic hypogonadism 13 with or without anosmia | | | | 3 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | KISS1 CL E G H | 3814 | 6341 | OMIM:614842 | Hypogonadotropic hypogonadism 13 with or without anosmia | | | | 3 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | KISS1R CL E G H | 84634 | 4510 | OMIM:176400 | Precocious puberty, central | | | | 14 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | KISS1R CL E G H | 84634 | 4510 | OMIM:176400 | Precocious puberty, central | | | | 14 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | KISS1R CL E G H | 84634 | 4510 | OMIM:176400 | Precocious puberty, central | | | | 14 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | KLHL10 CL E G H | 317719 | 18829 | ORPHA:399805 | Male infertility with azoospermia or oligozoospermia due to single gene mutation | HP:0040281 - Very frequent | | | 3 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | LARS2 CL E G H | 23395 | 17095 | OMIM:615300 | Perrault syndrome 4 | | | | 54 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | LGR4 CL E G H | 55366 | 13299 | OMIM:619613 | DELAYED PUBERTY, SELF-LIMITED; DPSL | | | | 1 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | LGR4 CL E G H | 55366 | 13299 | OMIM:619613 | DELAYED PUBERTY, SELF-LIMITED; DPSL | | | | 1 | | |
HP:0030338 | HP:0030339 | Decreased circulating gonadotropin concentration | 1 | LGR4 CL E G H | 55366 | 13299 | OMIM:619613 | DELAYED PUBERTY, SELF-LIMITED; DPSL | | | | 1 | | |
HP:0030338 | HP:0030339 | Decreased circulating gonadotropin concentration | 1 | LHB CL E G H | 3972 | 6584 | OMIM:228300 | Hypogonadotropic hypogonadism 23 without anosmia | | | | 9 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | LHB CL E G H | 3972 | 6584 | OMIM:228300 | Hypogonadotropic hypogonadism 23 without anosmia | | | | 9 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | LHB CL E G H | 3972 | 6584 | OMIM:228300 | Hypogonadotropic hypogonadism 23 without anosmia | | | | 9 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | LHB CL E G H | 3972 | 6584 | OMIM:228300 | Hypogonadotropic hypogonadism 23 without anosmia | | | | 9 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | LHCGR CL E G H | 3973 | 6585 | OMIM:238320 | Hypergonadotropic hypogonadism | . | | | 67 | | |
HP:0030338 | HP:0030339 | Decreased circulating gonadotropin concentration | 1 | LHX3 CL E G H | 8022 | 6595 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | | | | 51 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | LHX3 CL E G H | 8022 | 6595 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | | | | 51 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | LHX3 CL E G H | 8022 | 6595 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | | | | 51 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | LHX4 CL E G H | 89884 | 21734 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | | | | 43 | | |
HP:0030338 | HP:0030339 | Decreased circulating gonadotropin concentration | 1 | LHX4 CL E G H | 89884 | 21734 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | | | | 43 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | LHX4 CL E G H | 89884 | 21734 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | | | | 43 | | |
HP:0030338 | HP:0030339 | Decreased circulating gonadotropin concentration | 1 | MAGEL2 CL E G H | 54551 | 6814 | ORPHA:98754 | Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15 | HP:0040282 - Frequent | | | 63 | | |
HP:0030338 | HP:0030339 | Decreased circulating gonadotropin concentration | 1 | MAGEL2 CL E G H | 54551 | 6814 | ORPHA:177901 | Prader-Willi syndrome due to paternal deletion of 15q11q13 type 1 | HP:0040282 - Frequent | | | 63 | | |
HP:0030338 | HP:0030339 | Decreased circulating gonadotropin concentration | 1 | MAGEL2 CL E G H | 54551 | 6814 | ORPHA:177904 | Prader-Willi syndrome due to paternal deletion of 15q11q13 type 2 | HP:0040282 - Frequent | | | 63 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | MAP3K1 CL E G H | 4214 | 6848 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | HP:0040281 - Very frequent | | | 13 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | MAP3K1 CL E G H | 4214 | 6848 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | | | | 13 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | MAP3K1 CL E G H | 4214 | 6848 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | | | | 13 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | MCM8 CL E G H | 84515 | 16147 | OMIM:612885 | Premature ovarian failure 10 | | | | 4 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | MCM8 CL E G H | 84515 | 16147 | OMIM:612885 | Premature ovarian failure 10 | | | | 4 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | MCM8 CL E G H | 84515 | 16147 | OMIM:612885 | Premature ovarian failure 10 | | | | 4 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | MCM9 CL E G H | 254394 | 21484 | OMIM:616185 | Ovarian dysgenesis 4 | | | | 4 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | MCM9 CL E G H | 254394 | 21484 | OMIM:616185 | Ovarian dysgenesis 4 | | | | 4 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | MEIOB CL E G H | 254528 | 28569 | ORPHA:399805 | Male infertility with azoospermia or oligozoospermia due to single gene mutation | HP:0040281 - Very frequent | | | | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | MRPS22 CL E G H | 56945 | 14508 | ORPHA:243 | 46,XX gonadal dysgenesis | HP:0040281 - Very frequent | | | 25 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | MSH4 CL E G H | 4438 | 7327 | OMIM:619938 | | | | | | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | MSH4 CL E G H | 4438 | 7327 | OMIM:619938 | | | | | | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | MSH4 CL E G H | 4438 | 7327 | OMIM:619938 | | | | | | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | MSH5 CL E G H | 4439 | 7328 | OMIM:617442 | Premature ovarian failure 13 | | | | 5 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | MSH5 CL E G H | 4439 | 7328 | OMIM:617442 | Premature ovarian failure 13 | | | | 5 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | NANOS1 CL E G H | 340719 | 23044 | ORPHA:399805 | Male infertility with azoospermia or oligozoospermia due to single gene mutation | HP:0040281 - Very frequent | | | 4 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | NANOS1 CL E G H | 340719 | 23044 | ORPHA:399808 | Male infertility with teratozoospermia due to single gene mutation | HP:0040281 - Very frequent | | | 4 | | |
HP:0030338 | HP:0030339 | Decreased circulating gonadotropin concentration | 1 | NDN CL E G H | 4692 | 7675 | ORPHA:98754 | Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15 | HP:0040282 - Frequent | | | | | |
HP:0030338 | HP:0030339 | Decreased circulating gonadotropin concentration | 1 | NDN CL E G H | 4692 | 7675 | ORPHA:177901 | Prader-Willi syndrome due to paternal deletion of 15q11q13 type 1 | HP:0040282 - Frequent | | | | | |
HP:0030338 | HP:0030339 | Decreased circulating gonadotropin concentration | 1 | NDN CL E G H | 4692 | 7675 | ORPHA:177904 | Prader-Willi syndrome due to paternal deletion of 15q11q13 type 2 | HP:0040282 - Frequent | | | | | |
HP:0030338 | HP:0030339 | Decreased circulating gonadotropin concentration | 1 | NF2 CL E G H | 4771 | 7773 | ORPHA:2495 | Meningioma | | | | 220 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | NF2 CL E G H | 4771 | 7773 | ORPHA:2495 | Meningioma | | | | 220 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | NF2 CL E G H | 4771 | 7773 | ORPHA:2495 | Meningioma | | | | 220 | | |
HP:0030338 | HP:0030339 | Decreased circulating gonadotropin concentration | 1 | NHLH2 CL E G H | 4808 | 7818 | OMIM:619755 | HYPOGONADOTROPIC HYPOGONADISM 27 WITHOUT ANOSMIA; HH27 | | | | | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | NHLH2 CL E G H | 4808 | 7818 | OMIM:619755 | HYPOGONADOTROPIC HYPOGONADISM 27 WITHOUT ANOSMIA; HH27 | | | | | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | NHLH2 CL E G H | 4808 | 7818 | OMIM:619755 | HYPOGONADOTROPIC HYPOGONADISM 27 WITHOUT ANOSMIA; HH27 | | | | | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | NR0B1 CL E G H | 190 | 7960 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | | | | 48 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | NR0B1 CL E G H | 190 | 7960 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | HP:0040281 - Very frequent | | | 48 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | NR0B1 CL E G H | 190 | 7960 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | | | | 48 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | NR5A1 CL E G H | 2516 | 7983 | ORPHA:243 | 46,XX gonadal dysgenesis | HP:0040281 - Very frequent | | | 38 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | NR5A1 CL E G H | 2516 | 7983 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | HP:0040281 - Very frequent | | | 38 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | NR5A1 CL E G H | 2516 | 7983 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | | | | 38 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | NR5A1 CL E G H | 2516 | 7983 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | | | | 38 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | NR5A1 CL E G H | 2516 | 7983 | OMIM:612965 | 46XY sex reversal 3 | | | | 38 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | NR5A1 CL E G H | 2516 | 7983 | OMIM:612965 | 46XY sex reversal 3 | | | | 38 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | NR5A1 CL E G H | 2516 | 7983 | OMIM:612965 | 46XY sex reversal 3 | | | | 38 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | NR5A1 CL E G H | 2516 | 7983 | ORPHA:399805 | Male infertility with azoospermia or oligozoospermia due to single gene mutation | HP:0040281 - Very frequent | | | 38 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | NR5A1 CL E G H | 2516 | 7983 | OMIM:612964 | PREMATURE OVARIAN FAILURE 7; POF7 | | | | 38 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | NR5A1 CL E G H | 2516 | 7983 | OMIM:612964 | PREMATURE OVARIAN FAILURE 7; POF7 | | | | 38 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | NR5A1 CL E G H | 2516 | 7983 | OMIM:612964 | PREMATURE OVARIAN FAILURE 7; POF7 | | | | 38 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | NSMCE2 CL E G H | 286053 | 26513 | OMIM:617253 | Seckel syndrome 10 | | | | 2 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | NSMCE2 CL E G H | 286053 | 26513 | OMIM:617253 | Seckel syndrome 10 | | | | 2 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | NSMCE2 CL E G H | 286053 | 26513 | OMIM:617253 | Seckel syndrome 10 | | | | 2 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | NUP107 CL E G H | 57122 | 29914 | ORPHA:243 | 46,XX gonadal dysgenesis | HP:0040281 - Very frequent | | | 5 | | |
HP:0030338 | HP:0030339 | Decreased circulating gonadotropin concentration | 1 | OCA2 CL E G H | 4948 | 8101 | ORPHA:98754 | Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15 | HP:0040282 - Frequent | | | 121 | | |
HP:0030338 | HP:0030339 | Decreased circulating gonadotropin concentration | 1 | OCA2 CL E G H | 4948 | 8101 | ORPHA:177901 | Prader-Willi syndrome due to paternal deletion of 15q11q13 type 1 | HP:0040282 - Frequent | | | 121 | | |
HP:0030338 | HP:0030339 | Decreased circulating gonadotropin concentration | 1 | OCA2 CL E G H | 4948 | 8101 | ORPHA:177904 | Prader-Willi syndrome due to paternal deletion of 15q11q13 type 2 | HP:0040282 - Frequent | | | 121 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | OTX2 CL E G H | 5015 | 8522 | OMIM:613986 | Pituitary hormone deficiency, combined, 6 | | | | 41 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | OTX2 CL E G H | 5015 | 8522 | OMIM:613986 | Pituitary hormone deficiency, combined, 6 | | | | 41 | | |
HP:0030338 | HP:0030339 | Decreased circulating gonadotropin concentration | 1 | OTX2 CL E G H | 5015 | 8522 | OMIM:613986 | Pituitary hormone deficiency, combined, 6 | | | | 41 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | PDGFB CL E G H | 5155 | 8800 | ORPHA:2495 | Meningioma | | | | 9 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | PDGFB CL E G H | 5155 | 8800 | ORPHA:2495 | Meningioma | | | | 9 | | |
HP:0030338 | HP:0030339 | Decreased circulating gonadotropin concentration | 1 | PDGFB CL E G H | 5155 | 8800 | ORPHA:2495 | Meningioma | | | | 9 | | |
HP:0030338 | HP:0030339 | Decreased circulating gonadotropin concentration | 1 | PIK3CA CL E G H | 5290 | 8975 | ORPHA:2495 | Meningioma | | | | 162 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | PIK3CA CL E G H | 5290 | 8975 | ORPHA:2495 | Meningioma | | | | 162 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | PIK3CA CL E G H | 5290 | 8975 | ORPHA:2495 | Meningioma | | | | 162 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | PNLDC1 CL E G H | 154197 | 21185 | ORPHA:399805 | Male infertility with azoospermia or oligozoospermia due to single gene mutation | HP:0040281 - Very frequent | | | | | |
HP:0030338 | HP:0030339 | Decreased circulating gonadotropin concentration | 1 | PNPLA6 CL E G H | 10908 | 16268 | OMIM:215470 | Boucher-Neuhauser syndrome | | | | 103 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | POLA1 CL E G H | 5422 | 9173 | ORPHA:163976 | X-linked intellectual disability, Van Esch type | HP:0040282 - Frequent | | | 2 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | POLR3H CL E G H | 171568 | 30349 | ORPHA:243 | 46,XX gonadal dysgenesis | HP:0040281 - Very frequent | | | | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | POR CL E G H | 5447 | 9208 | ORPHA:95699 | Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency | | | | 76 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | POR CL E G H | 5447 | 9208 | ORPHA:95699 | Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency | | | | 76 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | POR CL E G H | 5447 | 9208 | ORPHA:95699 | Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency | | | | 76 | | |
HP:0030338 | HP:0030339 | Decreased circulating gonadotropin concentration | 1 | POU1F1 CL E G H | 5449 | 9210 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | | | | 36 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | POU1F1 CL E G H | 5449 | 9210 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | | | | 36 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | POU1F1 CL E G H | 5449 | 9210 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | | | | 36 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | PPP2R3C CL E G H | 55012 | 17485 | OMIM:618419 | Gonadal dysgenesis, dysmorphic facies, retinal dystrophy, and myopathy | | | | | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | PPP2R3C CL E G H | 55012 | 17485 | OMIM:618419 | Gonadal dysgenesis, dysmorphic facies, retinal dystrophy, and myopathy | | | | | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | PPP2R3C CL E G H | 55012 | 17485 | OMIM:618419 | Gonadal dysgenesis, dysmorphic facies, retinal dystrophy, and myopathy | | | | | | |
HP:0030338 | HP:0030339 | Decreased circulating gonadotropin concentration | 1 | PRDM13 CL E G H | 59336 | 13998 | OMIM:619761 | CEREBELLAR DYSFUNCTION, IMPAIRED INTELLECTUAL DEVELOPMENT, AND HYPOGONADOTROPIC HYPOGONADISM; CDIDHH | | | | 2 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | PRDM13 CL E G H | 59336 | 13998 | OMIM:619761 | CEREBELLAR DYSFUNCTION, IMPAIRED INTELLECTUAL DEVELOPMENT, AND HYPOGONADOTROPIC HYPOGONADISM; CDIDHH | | | | 2 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | PRDM13 CL E G H | 59336 | 13998 | OMIM:619761 | CEREBELLAR DYSFUNCTION, IMPAIRED INTELLECTUAL DEVELOPMENT, AND HYPOGONADOTROPIC HYPOGONADISM; CDIDHH | | | | 2 | | |
HP:0030338 | HP:0030339 | Decreased circulating gonadotropin concentration | 1 | PROP1 CL E G H | 5626 | 9455 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | | | | 54 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | PROP1 CL E G H | 5626 | 9455 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | | | | 54 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | PROP1 CL E G H | 5626 | 9455 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | | | | 54 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | PSMC3IP CL E G H | 29893 | 17928 | ORPHA:243 | 46,XX gonadal dysgenesis | HP:0040281 - Very frequent | | | 2 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | PSMC3IP CL E G H | 29893 | 17928 | OMIM:614324 | Ovarian dysgenesis 3 | | | | 2 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | PSMC3IP CL E G H | 29893 | 17928 | OMIM:614324 | Ovarian dysgenesis 3 | | | | 2 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | PSMC3IP CL E G H | 29893 | 17928 | OMIM:614324 | Ovarian dysgenesis 3 | | | | 2 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | SEMA3A CL E G H | 10371 | 10723 | OMIM:614897 | Hypogonadotropic hypogonadism 16 with or without anosmia | | | | 14 | | |
HP:0030338 | HP:0030339 | Decreased circulating gonadotropin concentration | 1 | SEMA3A CL E G H | 10371 | 10723 | OMIM:614897 | Hypogonadotropic hypogonadism 16 with or without anosmia | | | | 14 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | SEMA3A CL E G H | 10371 | 10723 | OMIM:614897 | Hypogonadotropic hypogonadism 16 with or without anosmia | | | | 14 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | SHOC1 CL E G H | 158401 | 26535 | OMIM:619949 | | | | | | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | SHOC1 CL E G H | 158401 | 26535 | OMIM:619949 | | | | | | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | SMARCB1 CL E G H | 6598 | 11103 | ORPHA:2495 | Meningioma | | | | 87 | | |
HP:0030338 | HP:0030339 | Decreased circulating gonadotropin concentration | 1 | SMARCB1 CL E G H | 6598 | 11103 | ORPHA:2495 | Meningioma | | | | 87 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | SMARCB1 CL E G H | 6598 | 11103 | ORPHA:2495 | Meningioma | | | | 87 | | |
HP:0030338 | HP:0030339 | Decreased circulating gonadotropin concentration | 1 | SMARCE1 CL E G H | 6605 | 11109 | ORPHA:2495 | Meningioma | | | | 47 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | SMARCE1 CL E G H | 6605 | 11109 | ORPHA:2495 | Meningioma | | | | 47 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | SMARCE1 CL E G H | 6605 | 11109 | ORPHA:2495 | Meningioma | | | | 47 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | SMO CL E G H | 6608 | 11119 | ORPHA:2495 | Meningioma | | | | 22 | | |
HP:0030338 | HP:0030339 | Decreased circulating gonadotropin concentration | 1 | SMO CL E G H | 6608 | 11119 | ORPHA:2495 | Meningioma | | | | 22 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | SMO CL E G H | 6608 | 11119 | ORPHA:2495 | Meningioma | | | | 22 | | |
HP:0030338 | HP:0030339 | Decreased circulating gonadotropin concentration | 1 | SNRPN CL E G H | 6638 | 11164 | ORPHA:98754 | Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15 | HP:0040282 - Frequent | | | 37 | | |
HP:0030338 | HP:0030339 | Decreased circulating gonadotropin concentration | 1 | SNRPN CL E G H | 6638 | 11164 | ORPHA:177901 | Prader-Willi syndrome due to paternal deletion of 15q11q13 type 1 | HP:0040282 - Frequent | | | 37 | | |
HP:0030338 | HP:0030339 | Decreased circulating gonadotropin concentration | 1 | SNRPN CL E G H | 6638 | 11164 | ORPHA:177904 | Prader-Willi syndrome due to paternal deletion of 15q11q13 type 2 | HP:0040282 - Frequent | | | 37 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | SOHLH1 CL E G H | 402381 | 27845 | ORPHA:399805 | Male infertility with azoospermia or oligozoospermia due to single gene mutation | HP:0040281 - Very frequent | | | 3 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | SOX9 CL E G H | 6662 | 11204 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | | | | 109 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | SOX9 CL E G H | 6662 | 11204 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | | | | 109 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | SOX9 CL E G H | 6662 | 11204 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | HP:0040281 - Very frequent | | | 109 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | SPIDR CL E G H | 23514 | 28971 | ORPHA:243 | 46,XX gonadal dysgenesis | HP:0040281 - Very frequent | | | 2 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | SPIDR CL E G H | 23514 | 28971 | OMIM:619665 | OVARIAN DYSGENESIS 9; ODG9 | | | | 2 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | SPIDR CL E G H | 23514 | 28971 | OMIM:619665 | OVARIAN DYSGENESIS 9; ODG9 | | | | 2 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | SPIDR CL E G H | 23514 | 28971 | OMIM:619665 | OVARIAN DYSGENESIS 9; ODG9 | | | | 2 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | SRY CL E G H | 6736 | 11311 | ORPHA:1772 | 45,X/46,XY mixed gonadal dysgenesis | HP:0040282 - Frequent | | | 23 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | SRY CL E G H | 6736 | 11311 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | | | | 23 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | SRY CL E G H | 6736 | 11311 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | HP:0040281 - Very frequent | | | 23 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | SRY CL E G H | 6736 | 11311 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | | | | 23 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | SRY CL E G H | 6736 | 11311 | OMIM:400045 | 46XX sex reversal 1 | | | | 23 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | SRY CL E G H | 6736 | 11311 | OMIM:400045 | 46XX sex reversal 1 | | | | 23 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | SRY CL E G H | 6736 | 11311 | OMIM:400045 | 46XX sex reversal 1 | | | | 23 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | SRY CL E G H | 6736 | 11311 | OMIM:400044 | 46XY sex reversal 1 | | | | 23 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | SRY CL E G H | 6736 | 11311 | OMIM:400044 | 46XY sex reversal 1 | | | | 23 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | SRY CL E G H | 6736 | 11311 | OMIM:400044 | 46XY sex reversal 1 | | | | 23 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | STAG3 CL E G H | 10734 | 11356 | OMIM:615723 | Premature ovarian failure 8 | | | | 4 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | STAG3 CL E G H | 10734 | 11356 | OMIM:615723 | Premature ovarian failure 8 | | | | 4 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | STAG3 CL E G H | 10734 | 11356 | OMIM:615723 | Premature ovarian failure 8 | . | | | 4 | | |
HP:0030338 | HP:0030339 | Decreased circulating gonadotropin concentration | 1 | SUFU CL E G H | 51684 | 16466 | ORPHA:2495 | Meningioma | | | | 124 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | SUFU CL E G H | 51684 | 16466 | ORPHA:2495 | Meningioma | | | | 124 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | SUFU CL E G H | 51684 | 16466 | ORPHA:2495 | Meningioma | | | | 124 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | SYCE1 CL E G H | 93426 | 28852 | ORPHA:399805 | Male infertility with azoospermia or oligozoospermia due to single gene mutation | HP:0040281 - Very frequent | | | 4 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | SYCP3 CL E G H | 50511 | 18130 | ORPHA:399805 | Male infertility with azoospermia or oligozoospermia due to single gene mutation | HP:0040281 - Very frequent | | | 12 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | TAF4B CL E G H | 6875 | 11538 | ORPHA:399805 | Male infertility with azoospermia or oligozoospermia due to single gene mutation | HP:0040281 - Very frequent | | | 1 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | TDRD9 CL E G H | 122402 | 20122 | ORPHA:399805 | Male infertility with azoospermia or oligozoospermia due to single gene mutation | HP:0040281 - Very frequent | | | | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | TERT CL E G H | 7015 | 11730 | ORPHA:2495 | Meningioma | | | | 238 | | |
HP:0030338 | HP:0030339 | Decreased circulating gonadotropin concentration | 1 | TERT CL E G H | 7015 | 11730 | ORPHA:2495 | Meningioma | | | | 238 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | TERT CL E G H | 7015 | 11730 | ORPHA:2495 | Meningioma | | | | 238 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | TEX11 CL E G H | 56159 | 11733 | ORPHA:399805 | Male infertility with azoospermia or oligozoospermia due to single gene mutation | HP:0040281 - Very frequent | | | 5 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | TEX14 CL E G H | 56155 | 11737 | ORPHA:399805 | Male infertility with azoospermia or oligozoospermia due to single gene mutation | HP:0040281 - Very frequent | | | 1 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | TEX15 CL E G H | 56154 | 11738 | ORPHA:399805 | Male infertility with azoospermia or oligozoospermia due to single gene mutation | HP:0040281 - Very frequent | | | 1 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | TRAF7 CL E G H | 84231 | 20456 | ORPHA:2495 | Meningioma | | | | | | |
HP:0030338 | HP:0030339 | Decreased circulating gonadotropin concentration | 1 | TRAF7 CL E G H | 84231 | 20456 | ORPHA:2495 | Meningioma | | | | | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | TRAF7 CL E G H | 84231 | 20456 | ORPHA:2495 | Meningioma | | | | | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | VAMP7 CL E G H | 6845 | 11486 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | | | | 2 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | VAMP7 CL E G H | 6845 | 11486 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | | | | 2 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | VAMP7 CL E G H | 6845 | 11486 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | HP:0040281 - Very frequent | | | 2 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | WT1 CL E G H | 7490 | 12796 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | | | | 177 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | WT1 CL E G H | 7490 | 12796 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | | | | 177 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | WT1 CL E G H | 7490 | 12796 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | HP:0040281 - Very frequent | | | 177 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | WT1 CL E G H | 7490 | 12796 | ORPHA:347 | Frasier syndrome | HP:0040281 - Very frequent | | | 177 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | WWOX CL E G H | 51741 | 12799 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | HP:0040281 - Very frequent | | | 149 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | WWOX CL E G H | 51741 | 12799 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | | | | 149 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | WWOX CL E G H | 51741 | 12799 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | | | | 149 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | XRCC2 CL E G H | 7516 | 12829 | ORPHA:399805 | Male infertility with azoospermia or oligozoospermia due to single gene mutation | HP:0040281 - Very frequent | | | 125 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | XRCC2 CL E G H | 7516 | 12829 | OMIM:619146 | PREMATURE OVARIAN FAILURE 17; POF17 | | | | 125 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | XRCC2 CL E G H | 7516 | 12829 | OMIM:619146 | PREMATURE OVARIAN FAILURE 17; POF17 | | | | 125 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | XRCC2 CL E G H | 7516 | 12829 | OMIM:619146 | PREMATURE OVARIAN FAILURE 17; POF17 | | | | 125 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | ZFPM2 CL E G H | 23414 | 16700 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | | | | 31 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | ZFPM2 CL E G H | 23414 | 16700 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | HP:0040281 - Very frequent | | | 31 | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | ZFPM2 CL E G H | 23414 | 16700 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | | | | 31 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | ZMYND15 CL E G H | 84225 | 20997 | ORPHA:399805 | Male infertility with azoospermia or oligozoospermia due to single gene mutation | HP:0040281 - Very frequent | | | 1 | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | ZMYND15 CL E G H | 84225 | 20997 | OMIM:615842 | Spermatogenic failure 14 | | | | 1 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | ZMYND15 CL E G H | 84225 | 20997 | OMIM:615842 | Spermatogenic failure 14 | | | | 1 | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | ZSWIM7 CL E G H | 125150 | 26993 | ORPHA:243 | 46,XX gonadal dysgenesis | HP:0040281 - Very frequent | | | | | |
HP:0030338 | HP:0030346 | Abnormal circulating follicle-stimulating hormone concentration | 1 | ZSWIM7 CL E G H | 125150 | 26993 | OMIM:619834 | OVARIAN DYSGENESIS 10; ODG10 | | | | | | |
HP:0030338 | HP:0000837 | Increased circulating gonadotropin level | 1 | ZSWIM7 CL E G H | 125150 | 26993 | OMIM:619834 | OVARIAN DYSGENESIS 10; ODG10 | | | | | | |
HP:0030338 | HP:0030345 | Abnormal circulating luteinizing hormone concentration | 1 | ZSWIM7 CL E G H | 125150 | 26993 | OMIM:619834 | OVARIAN DYSGENESIS 10; ODG10 | | | | | | |
HP:0030338 | HP:0030341 | Decreased circulating follicle stimulating hormone concentration | 2 | AKT1 CL E G H | 207 | 391 | ORPHA:2495 | Meningioma | HP:0040282 - Frequent | | | 54 | | |
HP:0030338 | HP:0030344 | Decreased circulating luteinizing hormone level | 2 | AKT1 CL E G H | 207 | 391 | ORPHA:2495 | Meningioma | HP:0040282 - Frequent | | | 54 | | |
HP:0030338 | HP:0030344 | Decreased circulating luteinizing hormone level | 2 | ANOS1 CL E G H | 3730 | 6211 | OMIM:308700 | Hypogonadotropic hypogonadism 1 with or without anosmia | | | | 65 | | |
HP:0030338 | HP:0030341 | Decreased circulating follicle stimulating hormone concentration | 2 | ANOS1 CL E G H | 3730 | 6211 | OMIM:308700 | Hypogonadotropic hypogonadism 1 with or without anosmia | | | | 65 | | |
HP:0030338 | HP:0008232 | Elevated circulating follicle stimulating hormone level | 2 | AR CL E G H | 367 | 644 | OMIM:300068 | Androgen insensitivity syndrome | . | | | 125 | | |
HP:0030338 | HP:0011969 | Elevated circulating luteinizing hormone level | 2 | AR CL E G H | 367 | 644 | OMIM:300068 | Androgen insensitivity syndrome | . | | | 125 | | |
HP:0030338 | HP:0011969 | Elevated circulating luteinizing hormone level | 2 | AR CL E G H | 367 | 644 | ORPHA:99429 | Complete androgen insensitivity syndrome | HP:0040281 - Very frequent | | | 125 | | |
HP:0030338 | HP:0011969 | Elevated circulating luteinizing hormone level | 2 | AR CL E G H | 367 | 644 | ORPHA:90797 | Partial androgen insensitivity syndrome | HP:0040281 - Very frequent | | | 125 | | |
HP:0030338 | HP:0030344 | Decreased circulating luteinizing hormone level | 2 | BAP1 CL E G H | 8314 | 950 | ORPHA:2495 | Meningioma | HP:0040282 - Frequent | | | 184 | | |
HP:0030338 | HP:0030341 | Decreased circulating follicle stimulating hormone concentration | 2 | BAP1 CL E G H | 8314 | 950 | ORPHA:2495 | Meningioma | HP:0040282 - Frequent | | | 184 | | |
HP:0030338 | HP:0008232 | Elevated circulating follicle stimulating hormone level | 2 | BMPR1B CL E G H | 658 | 1077 | OMIM:609441 | Acromesomelic dysplasia, Demirhan type | | | | 90 | | |
HP:0030338 | HP:0011969 | Elevated circulating luteinizing hormone level | 2 | BMPR1B CL E G H | 658 | 1077 | OMIM:609441 | Acromesomelic dysplasia, Demirhan type | | | | 90 | | |
HP:0030338 | HP:0008232 | Elevated circulating follicle stimulating hormone level | 2 | BNC1 CL E G H | 646 | 1081 | OMIM:618723 | PREMATURE OVARIAN FAILURE 16; POF16 | | | | | | |
HP:0030338 | HP:0008232 | Elevated circulating follicle stimulating hormone level | 2 | C14ORF39 CL E G H | 317761 | 19849 | OMIM:619203 | PREMATURE OVARIAN FAILURE 18; POF18 | | | | | | |
HP:0030338 | HP:0011969 | Elevated circulating luteinizing hormone level | 2 | C14ORF39 CL E G H | 317761 | 19849 | OMIM:619203 | PREMATURE OVARIAN FAILURE 18; POF18 | | | | | | |
HP:0030338 | HP:0008232 | Elevated circulating follicle stimulating hormone level | 2 | CBX2 CL E G H | 84733 | 1552 | OMIM:613080 | 46XY sex reversal 5 | . | | | 3 | | |
HP:0030338 | HP:0008232 | Elevated circulating follicle stimulating hormone level | 2 | CNBP CL E G H | 7555 | 13164 | OMIM:602668 | Dystrophia myotonica 2 | . | | | 1 | | |
HP:0030338 | HP:0030341 | Decreased circulating follicle stimulating hormone concentration | 2 | CPE CL E G H | 1363 | 2303 | OMIM:619326 | BDV SYNDROME; BDVS | | | | | | |
HP:0030338 | HP:0008232 | Elevated circulating follicle stimulating hormone level | 2 | CYB5A CL E G H | 1528 | 2570 | ORPHA:90796 | 46,XY disorder of sex development due to isolated 17,20-lyase deficiency | HP:0040281 - Very frequent | | | 2 | | |
HP:0030338 | HP:0011969 | Elevated circulating luteinizing hormone level | 2 | CYB5A CL E G H | 1528 | 2570 | ORPHA:90796 | 46,XY disorder of sex development due to isolated 17,20-lyase deficiency | HP:0040281 - Very frequent | | | 2 | | |
HP:0030338 | HP:0011969 | Elevated circulating luteinizing hormone level | 2 | CYP11A1 CL E G H | 1583 | 2590 | ORPHA:168558 | 46,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency | HP:0040282 - Frequent | | | 31 | | |
HP:0030338 | HP:0008232 | Elevated circulating follicle stimulating hormone level | 2 | CYP11A1 CL E G H | 1583 | 2590 | ORPHA:168558 | 46,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency | HP:0040282 - Frequent | | | 31 | | |
HP:0030338 | HP:0011969 | Elevated circulating luteinizing hormone level | 2 | CYP11A1 CL E G H | 1583 | 2590 | ORPHA:289548 | Inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency | HP:0040282 - Frequent | | | 31 | | |
HP:0030338 | HP:0008232 | Elevated circulating follicle stimulating hormone level | 2 | CYP11A1 CL E G H | 1583 | 2590 | ORPHA:289548 | Inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency | HP:0040282 - Frequent | | | 31 | | |
HP:0030338 | HP:0008232 | Elevated circulating follicle stimulating hormone level | 2 | CYP17A1 CL E G H | 1586 | 2593 | ORPHA:90796 | 46,XY disorder of sex development due to isolated 17,20-lyase deficiency | HP:0040281 - Very frequent | | | 53 | | |
HP:0030338 | HP:0011969 | Elevated circulating luteinizing hormone level | 2 | CYP17A1 CL E G H | 1586 | 2593 | ORPHA:90796 | 46,XY disorder of sex development due to isolated 17,20-lyase deficiency | HP:0040281 - Very frequent | | | 53 | | |
HP:0030338 | HP:0008232 | Elevated circulating follicle stimulating hormone level | 2 | CYP17A1 CL E G H | 1586 | 2593 | ORPHA:90793 | Congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency | HP:0040282 - Frequent | | | 53 | | |
HP:0030338 | HP:0011969 | Elevated circulating luteinizing hormone level | 2 | CYP17A1 CL E G H | 1586 | 2593 | ORPHA:90793 | Congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency | HP:0040282 - Frequent | | | 53 | | |
HP:0030338 | HP:0011969 | Elevated circulating luteinizing hormone level | 2 | DHX37 CL E G H | 57647 | 17210 | OMIM:273250 | 46, XY sex reversal 11 | | | | 2 | | |
HP:0030338 | HP:0008232 | Elevated circulating follicle stimulating hormone level | 2 | DHX37 CL E G H | 57647 | 17210 | OMIM:273250 | 46, XY sex reversal 11 | | | | 2 | | |
HP:0030338 | HP:0008232 | Elevated circulating follicle stimulating hormone level | 2 | DHX37 CL E G H | 57647 | 17210 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | HP:0040281 - Very frequent | | | 2 | | |
HP:0030338 | HP:0011969 | Elevated circulating luteinizing hormone level | 2 | DHX37 CL E G H | 57647 | 17210 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | HP:0040281 - Very frequent | | | 2 | | |
HP:0030338 | HP:0011969 | Elevated circulating luteinizing hormone level | 2 | DIAPH2 CL E G H | 1730 | 2877 | OMIM:300511 | Premature ovarian failure 2A | | | | 6 | | |
HP:0030338 | HP:0008232 | Elevated circulating follicle stimulating hormone level | 2 | DIAPH2 CL E G H | 1730 | 2877 | OMIM:300511 | Premature ovarian failure 2A | | | | 6 | | |
HP:0030338 | HP:0008232 | Elevated circulating follicle stimulating hormone level | 2 | DMRT3 CL E G H | 58524 | 13909 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | HP:0040281 - Very frequent | | | 1 | | |
HP:0030338 | HP:0011969 | Elevated circulating luteinizing hormone level | 2 | DMRT3 CL E G H | 58524 | 13909 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | HP:0040281 - Very frequent | | | 1 | | |
HP:0030338 | HP:0030341 | Decreased circulating follicle stimulating hormone concentration | 2 | DMXL2 CL E G H | 23312 | 2938 | ORPHA:453533 | Polyendocrine-polyneuropathy syndrome | HP:0040282 - Frequent | | | 3 | | |
HP:0030338 | HP:0030344 | Decreased circulating luteinizing hormone level | 2 | DMXL2 CL E G H | 23312 | 2938 | ORPHA:453533 | Polyendocrine-polyneuropathy syndrome | HP:0040282 - Frequent | | | 3 | | |
HP:0030338 | HP:0008232 | Elevated circulating follicle stimulating hormone level | 2 | ERCC6 CL E G H | 2074 | 3438 | OMIM:616946 | PREMATURE OVARIAN FAILURE 11; POF11 | | | | 199 | | |
HP:0030338 | HP:0011969 | Elevated circulating luteinizing hormone level | 2 | ESR2 CL E G H | 2100 | 3468 | OMIM:618187 | Ovarian dysgenesis 8 | . | | | | | |
HP:0030338 | HP:0008232 | Elevated circulating follicle stimulating hormone level | 2 | ESR2 CL E G H | 2100 | 3468 | OMIM:618187 | Ovarian dysgenesis 8 | . | | | | | |
HP:0030338 | HP:0008232 | Elevated circulating follicle stimulating hormone level | 2 | FANCM CL E G H | 57697 | 23168 | OMIM:618086 | Spermatogenic failure 28 | . | | | 107 | | |
HP:0030338 | HP:0011969 | Elevated circulating luteinizing hormone level | 2 | FANCM CL E G H | 57697 | 23168 | OMIM:618086 | Spermatogenic failure 28 | . | | | 107 | | |
HP:0030338 | HP:0008232 | Elevated circulating follicle stimulating hormone level | 2 | FGD1 CL E G H | 2245 | 3663 | OMIM:305400 | Aarskog-Scott syndrome | | | | 62 | | |
HP:0030338 | HP:0011969 | Elevated circulating luteinizing hormone level | 2 | FGD1 CL E G H | 2245 | 3663 | OMIM:305400 | Aarskog-Scott syndrome | | | | 62 | | |
HP:0030338 | HP:0011969 | Elevated circulating luteinizing hormone level | 2 | FIGLA CL E G H | 344018 | 24669 | OMIM:612310 | PREMATURE OVARIAN FAILURE 6; POF6 | | | | 17 | | |
HP:0030338 | HP:0008232 | Elevated circulating follicle stimulating hormone level | 2 | FIGLA CL E G H | 344018 | 24669 | OMIM:612310 | PREMATURE OVARIAN FAILURE 6; POF6 | | | | 17 | | |
HP:0030338 | HP:0008232 | Elevated circulating follicle stimulating hormone level | 2 | FKBP6 CL E G H | 8468 | 3722 | OMIM:620103 | | | | | | | |
HP:0030338 | HP:0008232 | Elevated circulating follicle stimulating hormone level | 2 | FOXL2 CL E G H | 668 | 1092 | ORPHA:572333 | Blepharophimosis-ptosis-epicanthus inversus syndrome plus | HP:0040283 - Occasional | | | 92 | | |
HP:0030338 | HP:0011969 | Elevated circulating luteinizing hormone level | 2 | FOXL2 CL E G H | 668 | 1092 | ORPHA:572333 | Blepharophimosis-ptosis-epicanthus inversus syndrome plus | HP:0040283 - Occasional | | | 92 | | |
HP:0030338 | HP:0030341 | Decreased circulating follicle stimulating hormone concentration | 2 | FSHB CL E G H | 2488 | 3964 | OMIM:229070 | Hypogonadotropic hypogonadism 24 without anosmia | | | | 23 | | |
HP:0030338 | HP:0011969 | Elevated circulating luteinizing hormone level | 2 | FSHB CL E G H | 2488 | 3964 | OMIM:229070 | Hypogonadotropic hypogonadism 24 without anosmia | | | | 23 | | |
HP:0030338 | HP:0008232 | Elevated circulating follicle stimulating hormone level | 2 | GATA4 CL E G H | 2626 | 4173 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | HP:0040281 - Very frequent | | | 87 | | |
HP:0030338 | HP:0011969 | Elevated circulating luteinizing hormone level | 2 | GATA4 CL E G H | 2626 | 4173 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | HP:0040281 - Very frequent | | | 87 | | |
HP:0030338 | HP:0011969 | Elevated circulating luteinizing hormone level | 2 | GCNA CL E G H | 93953 | 15805 | OMIM:301077 | SPERMATOGENIC FAILURE, X-LINKED, 4; SPGFX4 | | | | | | |
HP:0030338 | HP:0008232 | Elevated circulating follicle stimulating hormone level | 2 | GCNA CL E G H | 93953 | 15805 | OMIM:301077 | SPERMATOGENIC FAILURE, X-LINKED, 4; SPGFX4 | | | | | | |
HP:0030338 | HP:0008232 | Elevated circulating follicle stimulating hormone level | 2 | GDF9 CL E G H | 2661 | 4224 | OMIM:618014 | Premature ovarian failure 14 | . | | | 2 | | |
HP:0030338 | HP:0011969 | Elevated circulating luteinizing hormone level | 2 | GDF9 CL E G H | 2661 | 4224 | OMIM:618014 | Premature ovarian failure 14 | . | | | 2 | | |
HP:0030338 | HP:0030344 | Decreased circulating luteinizing hormone level | 2 | HESX1 CL E G H | 8820 | 4877 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | HP:0040283 - Occasional | | | 21 | | |
HP:0030338 | HP:0030341 | Decreased circulating follicle stimulating hormone concentration | 2 | HESX1 CL E G H | 8820 | 4877 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | HP:0040283 - Occasional | | | 21 | | |
HP:0030338 | HP:0030341 | Decreased circulating follicle stimulating hormone concentration | 2 | KISS1 CL E G H | 3814 | 6341 | OMIM:614842 | Hypogonadotropic hypogonadism 13 with or without anosmia | | | | 3 | | |
HP:0030338 | HP:0030344 | Decreased circulating luteinizing hormone level | 2 | KISS1 CL E G H | 3814 | 6341 | OMIM:614842 | Hypogonadotropic hypogonadism 13 with or without anosmia | | | | 3 | | |
HP:0030338 | HP:0008232 | Elevated circulating follicle stimulating hormone level | 2 | KISS1R CL E G H | 84634 | 4510 | OMIM:176400 | Precocious puberty, central | . | | | 14 | | |
HP:0030338 | HP:0011969 | Elevated circulating luteinizing hormone level | 2 | KISS1R CL E G H | 84634 | 4510 | OMIM:176400 | Precocious puberty, central | . | | | 14 | | |
HP:0030338 | HP:0030341 | Decreased circulating follicle stimulating hormone concentration | 2 | LGR4 CL E G H | 55366 | 13299 | OMIM:619613 | DELAYED PUBERTY, SELF-LIMITED; DPSL | | | | 1 | | |
HP:0030338 | HP:0030344 | Decreased circulating luteinizing hormone level | 2 | LGR4 CL E G H | 55366 | 13299 | OMIM:619613 | DELAYED PUBERTY, SELF-LIMITED; DPSL | | | | 1 | | |
HP:0030338 | HP:0030344 | Decreased circulating luteinizing hormone level | 2 | LHB CL E G H | 3972 | 6584 | OMIM:228300 | Hypogonadotropic hypogonadism 23 without anosmia | . | | | 9 | | |
HP:0030338 | HP:0008232 | Elevated circulating follicle stimulating hormone level | 2 | LHB CL E G H | 3972 | 6584 | OMIM:228300 | Hypogonadotropic hypogonadism 23 without anosmia | | | | 9 | | |
HP:0030338 | HP:0030341 | Decreased circulating follicle stimulating hormone concentration | 2 | LHX3 CL E G H | 8022 | 6595 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | HP:0040283 - Occasional | | | 51 | | |
HP:0030338 | HP:0030344 | Decreased circulating luteinizing hormone level | 2 | LHX3 CL E G H | 8022 | 6595 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | HP:0040283 - Occasional | | | 51 | | |
HP:0030338 | HP:0030344 | Decreased circulating luteinizing hormone level | 2 | LHX4 CL E G H | 89884 | 21734 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | HP:0040283 - Occasional | | | 43 | | |
HP:0030338 | HP:0030341 | Decreased circulating follicle stimulating hormone concentration | 2 | LHX4 CL E G H | 89884 | 21734 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | HP:0040283 - Occasional | | | 43 | | |
HP:0030338 | HP:0008232 | Elevated circulating follicle stimulating hormone level | 2 | MAP3K1 CL E G H | 4214 | 6848 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | HP:0040281 - Very frequent | | | 13 | | |
HP:0030338 | HP:0011969 | Elevated circulating luteinizing hormone level | 2 | MAP3K1 CL E G H | 4214 | 6848 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | HP:0040281 - Very frequent | | | 13 | | |
HP:0030338 | HP:0011969 | Elevated circulating luteinizing hormone level | 2 | MCM8 CL E G H | 84515 | 16147 | OMIM:612885 | Premature ovarian failure 10 | . | | | 4 | | |
HP:0030338 | HP:0008232 | Elevated circulating follicle stimulating hormone level | 2 | MCM8 CL E G H | 84515 | 16147 | OMIM:612885 | Premature ovarian failure 10 | | | | 4 | | |
HP:0030338 | HP:0008232 | Elevated circulating follicle stimulating hormone level | 2 | MCM9 CL E G H | 254394 | 21484 | OMIM:616185 | Ovarian dysgenesis 4 | | | | 4 | | |
HP:0030338 | HP:0008232 | Elevated circulating follicle stimulating hormone level | 2 | MSH4 CL E G H | 4438 | 7327 | OMIM:619938 | | | | | | | |
HP:0030338 | HP:0011969 | Elevated circulating luteinizing hormone level | 2 | MSH4 CL E G H | 4438 | 7327 | OMIM:619938 | | | | | | | |
HP:0030338 | HP:0008232 | Elevated circulating follicle stimulating hormone level | 2 | MSH5 CL E G H | 4439 | 7328 | OMIM:617442 | Premature ovarian failure 13 | | | | 5 | | |
HP:0030338 | HP:0030341 | Decreased circulating follicle stimulating hormone concentration | 2 | NF2 CL E G H | 4771 | 7773 | ORPHA:2495 | Meningioma | HP:0040282 - Frequent | | | 220 | | |
HP:0030338 | HP:0030344 | Decreased circulating luteinizing hormone level | 2 | NF2 CL E G H | 4771 | 7773 | ORPHA:2495 | Meningioma | HP:0040282 - Frequent | | | 220 | | |
HP:0030338 | HP:0030341 | Decreased circulating follicle stimulating hormone concentration | 2 | NHLH2 CL E G H | 4808 | 7818 | OMIM:619755 | HYPOGONADOTROPIC HYPOGONADISM 27 WITHOUT ANOSMIA; HH27 | | | | | | |
HP:0030338 | HP:0030344 | Decreased circulating luteinizing hormone level | 2 | NHLH2 CL E G H | 4808 | 7818 | OMIM:619755 | HYPOGONADOTROPIC HYPOGONADISM 27 WITHOUT ANOSMIA; HH27 | | | | | | |
HP:0030338 | HP:0008232 | Elevated circulating follicle stimulating hormone level | 2 | NR0B1 CL E G H | 190 | 7960 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | HP:0040281 - Very frequent | | | 48 | | |
HP:0030338 | HP:0011969 | Elevated circulating luteinizing hormone level | 2 | NR0B1 CL E G H | 190 | 7960 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | HP:0040281 - Very frequent | | | 48 | | |
HP:0030338 | HP:0011969 | Elevated circulating luteinizing hormone level | 2 | NR5A1 CL E G H | 2516 | 7983 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | HP:0040281 - Very frequent | | | 38 | | |
HP:0030338 | HP:0008232 | Elevated circulating follicle stimulating hormone level | 2 | NR5A1 CL E G H | 2516 | 7983 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | HP:0040281 - Very frequent | | | 38 | | |
HP:0030338 | HP:0008232 | Elevated circulating follicle stimulating hormone level | 2 | NR5A1 CL E G H | 2516 | 7983 | OMIM:612965 | 46XY sex reversal 3 | | | | 38 | | |
HP:0030338 | HP:0011969 | Elevated circulating luteinizing hormone level | 2 | NR5A1 CL E G H | 2516 | 7983 | OMIM:612965 | 46XY sex reversal 3 | | | | 38 | | |
HP:0030338 | HP:0011969 | Elevated circulating luteinizing hormone level | 2 | NR5A1 CL E G H | 2516 | 7983 | OMIM:612964 | PREMATURE OVARIAN FAILURE 7; POF7 | | | | 38 | | |
HP:0030338 | HP:0008232 | Elevated circulating follicle stimulating hormone level | 2 | NR5A1 CL E G H | 2516 | 7983 | OMIM:612964 | PREMATURE OVARIAN FAILURE 7; POF7 | | | | 38 | | |
HP:0030338 | HP:0011969 | Elevated circulating luteinizing hormone level | 2 | NSMCE2 CL E G H | 286053 | 26513 | OMIM:617253 | Seckel syndrome 10 | . | | | 2 | | |
HP:0030338 | HP:0008232 | Elevated circulating follicle stimulating hormone level | 2 | NSMCE2 CL E G H | 286053 | 26513 | OMIM:617253 | Seckel syndrome 10 | . | | | 2 | | |
HP:0030338 | HP:0030341 | Decreased circulating follicle stimulating hormone concentration | 2 | OTX2 CL E G H | 5015 | 8522 | OMIM:613986 | Pituitary hormone deficiency, combined, 6 | | | | 41 | | |
HP:0030338 | HP:0030344 | Decreased circulating luteinizing hormone level | 2 | OTX2 CL E G H | 5015 | 8522 | OMIM:613986 | Pituitary hormone deficiency, combined, 6 | | | | 41 | | |
HP:0030338 | HP:0030341 | Decreased circulating follicle stimulating hormone concentration | 2 | PDGFB CL E G H | 5155 | 8800 | ORPHA:2495 | Meningioma | HP:0040282 - Frequent | | | 9 | | |
HP:0030338 | HP:0030344 | Decreased circulating luteinizing hormone level | 2 | PDGFB CL E G H | 5155 | 8800 | ORPHA:2495 | Meningioma | HP:0040282 - Frequent | | | 9 | | |
HP:0030338 | HP:0030344 | Decreased circulating luteinizing hormone level | 2 | PIK3CA CL E G H | 5290 | 8975 | ORPHA:2495 | Meningioma | HP:0040282 - Frequent | | | 162 | | |
HP:0030338 | HP:0030341 | Decreased circulating follicle stimulating hormone concentration | 2 | PIK3CA CL E G H | 5290 | 8975 | ORPHA:2495 | Meningioma | HP:0040282 - Frequent | | | 162 | | |
HP:0030338 | HP:0008232 | Elevated circulating follicle stimulating hormone level | 2 | POR CL E G H | 5447 | 9208 | ORPHA:95699 | Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency | HP:0040283 - Occasional | | | 76 | | |
HP:0030338 | HP:0011969 | Elevated circulating luteinizing hormone level | 2 | POR CL E G H | 5447 | 9208 | ORPHA:95699 | Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency | HP:0040283 - Occasional | | | 76 | | |
HP:0030338 | HP:0030344 | Decreased circulating luteinizing hormone level | 2 | POU1F1 CL E G H | 5449 | 9210 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | HP:0040283 - Occasional | | | 36 | | |
HP:0030338 | HP:0030341 | Decreased circulating follicle stimulating hormone concentration | 2 | POU1F1 CL E G H | 5449 | 9210 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | HP:0040283 - Occasional | | | 36 | | |
HP:0030338 | HP:0008232 | Elevated circulating follicle stimulating hormone level | 2 | PPP2R3C CL E G H | 55012 | 17485 | OMIM:618419 | Gonadal dysgenesis, dysmorphic facies, retinal dystrophy, and myopathy | . | | | | | |
HP:0030338 | HP:0011969 | Elevated circulating luteinizing hormone level | 2 | PPP2R3C CL E G H | 55012 | 17485 | OMIM:618419 | Gonadal dysgenesis, dysmorphic facies, retinal dystrophy, and myopathy | . | | | | | |
HP:0030338 | HP:0030344 | Decreased circulating luteinizing hormone level | 2 | PRDM13 CL E G H | 59336 | 13998 | OMIM:619761 | CEREBELLAR DYSFUNCTION, IMPAIRED INTELLECTUAL DEVELOPMENT, AND HYPOGONADOTROPIC HYPOGONADISM; CDIDHH | | | | 2 | | |
HP:0030338 | HP:0030341 | Decreased circulating follicle stimulating hormone concentration | 2 | PRDM13 CL E G H | 59336 | 13998 | OMIM:619761 | CEREBELLAR DYSFUNCTION, IMPAIRED INTELLECTUAL DEVELOPMENT, AND HYPOGONADOTROPIC HYPOGONADISM; CDIDHH | | | | 2 | | |
HP:0030338 | HP:0030344 | Decreased circulating luteinizing hormone level | 2 | PROP1 CL E G H | 5626 | 9455 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | HP:0040283 - Occasional | | | 54 | | |
HP:0030338 | HP:0030341 | Decreased circulating follicle stimulating hormone concentration | 2 | PROP1 CL E G H | 5626 | 9455 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | HP:0040283 - Occasional | | | 54 | | |
HP:0030338 | HP:0011969 | Elevated circulating luteinizing hormone level | 2 | PSMC3IP CL E G H | 29893 | 17928 | OMIM:614324 | Ovarian dysgenesis 3 | | | | 2 | | |
HP:0030338 | HP:0008232 | Elevated circulating follicle stimulating hormone level | 2 | PSMC3IP CL E G H | 29893 | 17928 | OMIM:614324 | Ovarian dysgenesis 3 | | | | 2 | | |
HP:0030338 | HP:0030341 | Decreased circulating follicle stimulating hormone concentration | 2 | SEMA3A CL E G H | 10371 | 10723 | OMIM:614897 | Hypogonadotropic hypogonadism 16 with or without anosmia | | | | 14 | | |
HP:0030338 | HP:0030344 | Decreased circulating luteinizing hormone level | 2 | SEMA3A CL E G H | 10371 | 10723 | OMIM:614897 | Hypogonadotropic hypogonadism 16 with or without anosmia | | | | 14 | | |
HP:0030338 | HP:0008232 | Elevated circulating follicle stimulating hormone level | 2 | SHOC1 CL E G H | 158401 | 26535 | OMIM:619949 | | | | | | | |
HP:0030338 | HP:0030344 | Decreased circulating luteinizing hormone level | 2 | SMARCB1 CL E G H | 6598 | 11103 | ORPHA:2495 | Meningioma | HP:0040282 - Frequent | | | 87 | | |
HP:0030338 | HP:0030341 | Decreased circulating follicle stimulating hormone concentration | 2 | SMARCB1 CL E G H | 6598 | 11103 | ORPHA:2495 | Meningioma | HP:0040282 - Frequent | | | 87 | | |
HP:0030338 | HP:0030344 | Decreased circulating luteinizing hormone level | 2 | SMARCE1 CL E G H | 6605 | 11109 | ORPHA:2495 | Meningioma | HP:0040282 - Frequent | | | 47 | | |
HP:0030338 | HP:0030341 | Decreased circulating follicle stimulating hormone concentration | 2 | SMARCE1 CL E G H | 6605 | 11109 | ORPHA:2495 | Meningioma | HP:0040282 - Frequent | | | 47 | | |
HP:0030338 | HP:0030341 | Decreased circulating follicle stimulating hormone concentration | 2 | SMO CL E G H | 6608 | 11119 | ORPHA:2495 | Meningioma | HP:0040282 - Frequent | | | 22 | | |
HP:0030338 | HP:0030344 | Decreased circulating luteinizing hormone level | 2 | SMO CL E G H | 6608 | 11119 | ORPHA:2495 | Meningioma | HP:0040282 - Frequent | | | 22 | | |
HP:0030338 | HP:0011969 | Elevated circulating luteinizing hormone level | 2 | SOX9 CL E G H | 6662 | 11204 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | HP:0040281 - Very frequent | | | 109 | | |
HP:0030338 | HP:0008232 | Elevated circulating follicle stimulating hormone level | 2 | SOX9 CL E G H | 6662 | 11204 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | HP:0040281 - Very frequent | | | 109 | | |
HP:0030338 | HP:0008232 | Elevated circulating follicle stimulating hormone level | 2 | SPIDR CL E G H | 23514 | 28971 | OMIM:619665 | OVARIAN DYSGENESIS 9; ODG9 | | | | 2 | | |
HP:0030338 | HP:0011969 | Elevated circulating luteinizing hormone level | 2 | SPIDR CL E G H | 23514 | 28971 | OMIM:619665 | OVARIAN DYSGENESIS 9; ODG9 | | | | 2 | | |
HP:0030338 | HP:0011969 | Elevated circulating luteinizing hormone level | 2 | SRY CL E G H | 6736 | 11311 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | HP:0040281 - Very frequent | | | 23 | | |
HP:0030338 | HP:0008232 | Elevated circulating follicle stimulating hormone level | 2 | SRY CL E G H | 6736 | 11311 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | HP:0040281 - Very frequent | | | 23 | | |
HP:0030338 | HP:0008232 | Elevated circulating follicle stimulating hormone level | 2 | SRY CL E G H | 6736 | 11311 | OMIM:400045 | 46XX sex reversal 1 | . | | | 23 | | |
HP:0030338 | HP:0011969 | Elevated circulating luteinizing hormone level | 2 | SRY CL E G H | 6736 | 11311 | OMIM:400045 | 46XX sex reversal 1 | . | | | 23 | | |
HP:0030338 | HP:0011969 | Elevated circulating luteinizing hormone level | 2 | SRY CL E G H | 6736 | 11311 | OMIM:400044 | 46XY sex reversal 1 | . | | | 23 | | |
HP:0030338 | HP:0008232 | Elevated circulating follicle stimulating hormone level | 2 | SRY CL E G H | 6736 | 11311 | OMIM:400044 | 46XY sex reversal 1 | . | | | 23 | | |
HP:0030338 | HP:0011969 | Elevated circulating luteinizing hormone level | 2 | STAG3 CL E G H | 10734 | 11356 | OMIM:615723 | Premature ovarian failure 8 | | | | 4 | | |
HP:0030338 | HP:0008232 | Elevated circulating follicle stimulating hormone level | 2 | STAG3 CL E G H | 10734 | 11356 | OMIM:615723 | Premature ovarian failure 8 | | | | 4 | | |
HP:0030338 | HP:0030341 | Decreased circulating follicle stimulating hormone concentration | 2 | SUFU CL E G H | 51684 | 16466 | ORPHA:2495 | Meningioma | HP:0040282 - Frequent | | | 124 | | |
HP:0030338 | HP:0030344 | Decreased circulating luteinizing hormone level | 2 | SUFU CL E G H | 51684 | 16466 | ORPHA:2495 | Meningioma | HP:0040282 - Frequent | | | 124 | | |
HP:0030338 | HP:0030341 | Decreased circulating follicle stimulating hormone concentration | 2 | TERT CL E G H | 7015 | 11730 | ORPHA:2495 | Meningioma | HP:0040282 - Frequent | | | 238 | | |
HP:0030338 | HP:0030344 | Decreased circulating luteinizing hormone level | 2 | TERT CL E G H | 7015 | 11730 | ORPHA:2495 | Meningioma | HP:0040282 - Frequent | | | 238 | | |
HP:0030338 | HP:0030341 | Decreased circulating follicle stimulating hormone concentration | 2 | TRAF7 CL E G H | 84231 | 20456 | ORPHA:2495 | Meningioma | HP:0040282 - Frequent | | | | | |
HP:0030338 | HP:0030344 | Decreased circulating luteinizing hormone level | 2 | TRAF7 CL E G H | 84231 | 20456 | ORPHA:2495 | Meningioma | HP:0040282 - Frequent | | | | | |
HP:0030338 | HP:0011969 | Elevated circulating luteinizing hormone level | 2 | VAMP7 CL E G H | 6845 | 11486 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | HP:0040281 - Very frequent | | | 2 | | |
HP:0030338 | HP:0008232 | Elevated circulating follicle stimulating hormone level | 2 | VAMP7 CL E G H | 6845 | 11486 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | HP:0040281 - Very frequent | | | 2 | | |
HP:0030338 | HP:0011969 | Elevated circulating luteinizing hormone level | 2 | WT1 CL E G H | 7490 | 12796 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | HP:0040281 - Very frequent | | | 177 | | |
HP:0030338 | HP:0008232 | Elevated circulating follicle stimulating hormone level | 2 | WT1 CL E G H | 7490 | 12796 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | HP:0040281 - Very frequent | | | 177 | | |
HP:0030338 | HP:0011969 | Elevated circulating luteinizing hormone level | 2 | WWOX CL E G H | 51741 | 12799 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | HP:0040281 - Very frequent | | | 149 | | |
HP:0030338 | HP:0008232 | Elevated circulating follicle stimulating hormone level | 2 | WWOX CL E G H | 51741 | 12799 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | HP:0040281 - Very frequent | | | 149 | | |
HP:0030338 | HP:0008232 | Elevated circulating follicle stimulating hormone level | 2 | XRCC2 CL E G H | 7516 | 12829 | OMIM:619146 | PREMATURE OVARIAN FAILURE 17; POF17 | | | | 125 | | |
HP:0030338 | HP:0011969 | Elevated circulating luteinizing hormone level | 2 | XRCC2 CL E G H | 7516 | 12829 | OMIM:619146 | PREMATURE OVARIAN FAILURE 17; POF17 | | | | 125 | | |
HP:0030338 | HP:0011969 | Elevated circulating luteinizing hormone level | 2 | ZFPM2 CL E G H | 23414 | 16700 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | HP:0040281 - Very frequent | | | 31 | | |
HP:0030338 | HP:0008232 | Elevated circulating follicle stimulating hormone level | 2 | ZFPM2 CL E G H | 23414 | 16700 | ORPHA:251510 | 46,XY partial gonadal dysgenesis | HP:0040281 - Very frequent | | | 31 | | |
HP:0030338 | HP:0008232 | Elevated circulating follicle stimulating hormone level | 2 | ZMYND15 CL E G H | 84225 | 20997 | OMIM:615842 | Spermatogenic failure 14 | | | | 1 | | |
HP:0030338 | HP:0008232 | Elevated circulating follicle stimulating hormone level | 2 | ZSWIM7 CL E G H | 125150 | 26993 | OMIM:619834 | OVARIAN DYSGENESIS 10; ODG10 | | | | | | |
HP:0030338 | HP:0011969 | Elevated circulating luteinizing hormone level | 2 | ZSWIM7 CL E G H | 125150 | 26993 | OMIM:619834 | OVARIAN DYSGENESIS 10; ODG10 | | | | | | |